How much is Apogee Therapeutics worth in 2026?

Apogee Therapeutics has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Apogee Therapeutics raised?

Apogee Therapeutics has raised N/A in total funding across 1 funding rounds.

Apogee Therapeutics

Biotechnology

Apogee Therapeutics valuation and funding history | Last updated: December 7, 2022 | 1 funding rounds

Current Valuation

N/A

As of December 7, 2022

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series B)

$149.0M

Last Funding

Dec 2022

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 7, 2022	Early Stage VC (Series B)	$149.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Apogee Therapeutics is currently valued at N/A as of December 7, 2022.

Track Apogee Therapeutics Valuation Updates

Get notified when Apogee Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Apogee Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Apogee Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Apogee Therapeutics Worth in 2026?

Apogee Therapeutics is a leading private company in the Biotechnology sector. Track Apogee Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Apogee Therapeutics Valuation is Determined

Private company valuations like Apogee Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.